Immediate Impact
1 from Science/Nature 68 standout
Citing Papers
Lightweight and drift-free magnetically actuated millirobots via asymmetric laser-induced graphene
2024 Standout
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
Works of Ioannis Xanthakis being referenced
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis
2012
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ioannis Xanthakis | 340 | 156 | 125 | 30 | 506 | |
| Manabu Yamamoto | 231 | 249 | 116 | 26 | 546 | |
| Maria D. Begnami | 274 | 213 | 152 | 21 | 543 | |
| Hong Jo Choi | 272 | 169 | 171 | 25 | 536 | |
| David Saavedra-Pérez | 269 | 158 | 144 | 28 | 561 | |
| Kazunori Kanehira | 223 | 110 | 162 | 27 | 563 | |
| Katrin Bankov | 176 | 110 | 97 | 36 | 441 | |
| Vincenzo Rosario Iaffaioli | 310 | 76 | 105 | 25 | 511 | |
| Hao Zhang | 295 | 179 | 217 | 38 | 551 | |
| Matthew Chau Hsien Ng | 196 | 161 | 126 | 43 | 442 | |
| Maximillian Bockhorn | 191 | 115 | 170 | 28 | 467 |
All Works
Loading papers...